Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice

Prof Josep Llovet, Dr Richard Finn
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )
25 Feb 2019

Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA

Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018

Two important pancreatic studies: PRODIGE 24 and PREOPANC

Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA
Two important pancreatic studies: PRODIGE 24 and PREOPANC ( Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Aug 2018

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA
MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )
6 Jul 2018

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies
ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )
24 Jun 2018

Pancreatic survival improved with trial chemotherapy regimen after surgery

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Pancreatic survival improved with trial chemotherapy regimen after surgery ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
4 Jun 2018

Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen

Dr Andrew Epstein and Prof Richard Schilsky
Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Andrew Epstein and Prof Richard Schilsky )
4 Jun 2018

Pancreatic cancer survival extended by over a year with chemotherapy regimen

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
4 Jun 2018

New pathways in pancreatic cancer

Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA
New pathways in pancreatic cancer ( Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA )
3 Jun 2018

BLU-285 for advanced systemic mastocytosis

Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
BLU-285 for advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017

Precision Panc, a platform for pancreatic cancer

Prof Andrew Biankin - University of Glasgow, Glasgow, UK
Precision Panc, a platform for pancreatic cancer ( Prof Andrew Biankin - University of Glasgow, Glasgow, UK )
6 Dec 2017